Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Ryan

Showing results (251-260 of 274) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN Clinical Practice Guidelines in Oncology: colon cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN Clinical Practice Guidelines in Oncology: rectal cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 8, 2011
Colon cancerAl B Benson, J Pablo Arnoletti, Tanios Bekaii-Saab, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinomaRebecca L Porter, Neelima K C Magnus, Vishal Thapar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2010
NCCN clinical practice guidelines in oncology. Anal carcinomaPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Cancer Discovery|December 31, 2016
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive CholangiocarcinomaLipika Goyal, Supriya K Saha, Leah Y Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelinesAl B Benson, J Pablo Arnoletti, Tanios Bekaii-Saab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2014
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinomaDarrell R Borger, Lipika Goyal, Thomas Yau, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Rectal cancerAl B Benson, Tanios Bekaii-Saab, Emily Chan, et al.
Pageof 28

Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN Clinical Practice Guidelines in Oncology: colon cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN Clinical Practice Guidelines in Oncology: rectal cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 8, 2011
Colon cancerAl B Benson, J Pablo Arnoletti, Tanios Bekaii-Saab, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinomaRebecca L Porter, Neelima K C Magnus, Vishal Thapar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2010
NCCN clinical practice guidelines in oncology. Anal carcinomaPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Cancer Discovery|December 31, 2016
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive CholangiocarcinomaLipika Goyal, Supriya K Saha, Leah Y Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelinesAl B Benson, J Pablo Arnoletti, Tanios Bekaii-Saab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2014
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinomaDarrell R Borger, Lipika Goyal, Thomas Yau, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Rectal cancerAl B Benson, Tanios Bekaii-Saab, Emily Chan, et al.
Pageof 28